Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank64
3Y CAGR-22.4%
5Y CAGR-16.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-22.4%/yr
vs +12.1%/yr prior
5Y CAGR
-16.1%/yr
Recent deceleration
Acceleration
-34.5pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.86M | +35.2% |
| 2024 | $18.39M | -16.4% |
| 2023 | $22.01M | -58.7% |
| 2022 | $53.25M | -16.2% |
| 2021 | $63.52M | +6.0% |
| 2020 | $59.95M | +95.5% |
| 2019 | $30.67M | -9.0% |
| 2018 | $33.71M | +483.1% |
| 2017 | $5.78M | +205.5% |
| 2016 | $1.89M | - |